These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31489324)

  • 21. In whom, how and how often is surveillance for hepatocellular carcinoma cost-effective?
    Ruelas-Villavicencio AL; Vargas-Vorácková F
    Ann Hepatol; 2004; 3(4):152-9. PubMed ID: 15657557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma: surveillance CT schedule after hepatectomy based on risk stratification.
    Liu D; Fong DY; Chan AC; Poon RT; Khong PL
    Radiology; 2015 Jan; 274(1):133-40. PubMed ID: 25162308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surveillance for hepatocellular carcinoma: does it work?].
    Kchaou-Ouakaa A; Belhadjbrik N; Elloumi H; Gargouri D; Kochlef A; Kilani A; Romani M; Kharrat J; Ghorbel A
    Tunis Med; 2007 Oct; 85(10):866-70. PubMed ID: 18236810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
    Santi V; Trevisani F; Gramenzi A; Grignaschi A; Mirici-Cappa F; Del Poggio P; Di Nolfo MA; Benvegnù L; Farinati F; Zoli M; Giannini EG; Borzio F; Caturelli E; Chiaramonte M; Bernardi M;
    J Hepatol; 2010 Aug; 53(2):291-7. PubMed ID: 20483497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance for hepatocellular carcinoma.
    Ramachandran J
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S50-6. PubMed ID: 25755611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet.
    Wong GL
    World J Hepatol; 2015 Aug; 7(18):2133-5. PubMed ID: 26328024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study.
    Caturelli E; Solmi L; Anti M; Fusilli S; Roselli P; Andriulli A; Fornari F; Del Vecchio Blanco C; de Sio I
    Gut; 2004 Sep; 53(9):1356-62. PubMed ID: 15306600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.
    Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L
    J Clin Nurs; 2018 Jul; 27(13-14):2673-2683. PubMed ID: 29603817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.
    Yoshida H; Shiratori Y; Moriyama M; Arakawa Y; Ide T; Sata M; Inoue O; Yano M; Tanaka M; Fujiyama S; Nishiguchi S; Kuroki T; Imazeki F; Yokosuka O; Kinoyama S; Yamada G; Omata M
    Ann Intern Med; 1999 Aug; 131(3):174-81. PubMed ID: 10428733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Practice of Hepatocellular Carcinoma Surveillance.
    Loho IM; Siregar L; Waspodo AS; Hasan I
    Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current staging of hepatocellular carcinoma: imaging implications.
    Bhosale P; Szklaruk J; Silverman PM
    Cancer Imaging; 2006 Jul; 6(1):83-94. PubMed ID: 16829469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
    Lange N; Dufour JF
    Dig Dis Sci; 2019 Apr; 64(4):903-909. PubMed ID: 30863952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology, risk factors and surveillance of hepatocellular carcinoma.
    Cabibbo G; Craxì A
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):352-5. PubMed ID: 20496547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?
    Hanouneh IA; Alkhouri N; Singal AG
    Clin Mol Hepatol; 2019 Sep; 25(3):264-269. PubMed ID: 30827081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of α-fetoprotein for hepatocellular carcinoma surveillance: the return of the living-dead?
    Giannini EG; Erroi V; Trevisani F
    Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):441-4. PubMed ID: 22928896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is laparoscopic hepatectomy superior to open hepatectomy for hepatocellular carcinoma?
    Zhong JH; Peng NF; Gu JH; Zheng MH; Li LQ
    World J Hepatol; 2017 Feb; 9(4):167-170. PubMed ID: 28217254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
    Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
    Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).
    Kokudo N; Hasegawa K; Akahane M; Igaki H; Izumi N; Ichida T; Uemoto S; Kaneko S; Kawasaki S; Ku Y; Kudo M; Kubo S; Takayama T; Tateishi R; Fukuda T; Matsui O; Matsuyama Y; Murakami T; Arii S; Okazaki M; Makuuchi M
    Hepatol Res; 2015 Jan; 45(2):. PubMed ID: 25625806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of the surveillance program for hepatocellular carcinoma].
    Abe R; Okano J; Imamoto R; Fujise Y; Koda M; Murawaki Y
    Nihon Shokakibyo Gakkai Zasshi; 2012 May; 109(5):741-50. PubMed ID: 22688099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nurse-led hepatocellular carcinoma surveillance clinic provides an effective method of monitoring patients with cirrhosis.
    Nazareth S; Leembruggen N; Tuma R; Chen SL; Rao S; Kontorinis N; Cheng W
    Int J Nurs Pract; 2016 Jun; 22 Suppl 2():3-11. PubMed ID: 27476494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.